This week’s topics include the PROTECT-AF trial, the association of inpatient vs. outpatient onset of STEMI with treatment and clinical outcomes, and more.
Research on Circulation’s own published articles suggests that it probably does not.
This week’s topic is anticoagulant therapy during primary PCI for acute MI.
Ryan’s Rules for #AHA14 (16 Nov 2014)John Ryan, MD
John Ryan provides some helpful hints for managing your experience at the AHA 2014 cardiology conference.
AHA 2014: There’s an App for That (16 Nov 2014)Tariq Ahmad, MD, MPH
A fellow finds a convenient way to plan your activities at AHA.14.
AHA.14 Headquarters (15 Nov 2014)CardioExchange Administrator, Staff
News: Prolonged Dual Antiplatelet Therapy Affirmed in DAPT IMPROVE-IT Meets Endpoint and Demonstrates Real But Modest Clinical Benefit for Ezetimibe Large Japanese Trial Casts Further Doubt on Aspirin for Primary Prevention Perspectives: AHA 2014: There’s an App for That Ryan’s Rules for AHA.14
Tariq Ahmad discusses his research group’s study of clinical phenotypes in patients with chronic systolic heart failure.
This week’s topics include dual-antiplatelet treatment beyond one year after DES implantation, reappraisal of thienopyridine pretreatment in patients with non-ST elevation acute coronary syndrome, and more.
Traditional CVD Risk Factors Mediate Between Lifestyle Factors and Cardiovascular Risk in Women (27 Oct 2014)Nina P Paynter, PhD, MHS and Harlan M. Krumholz, MD, SM
Nina Paynter discusses her case-cohort study comparing lifestyle-based with traditional cardiovascular disease prediction among women in the Women’s Health Initiative Observational Study.
This week’s topics include behavioral counseling for those with CV risk factors, long-term outcomes after stenting vs. endarterectomy for treatment of symptomatic carotid stenosis, and more.